Market Place
Sourcing Support
Sunshine Lake Pharma`s Generic Aripiprazole Receives Approval in the U.S.
02 Oct 2023 //
FDA
Sunshine Lake Generic Alogliptin Receives Tentative Approval in US
09 Jan 2021 //
FDA
Sunshine Lake Generic Tadalafil Receives Approval in US
26 Nov 2020 //
FDA
Sunshine Lake Generic Febuxostat Receives Approval in US
17 Jun 2020 //
FDA
Sunshine Lake Generic Febuxostat Receives Approval in US
09 Jun 2020 //
FDA
Sunshine Lake Generic Entecavir Receives Approval in US
23 May 2020 //
FDA
Sunshine Lake Generic Solifenacin Succinate Receives Approval in US
15 Apr 2020 //
FDA
Sunshine Lake Generic Ranolazine Receives Approval in US
26 Mar 2020 //
FDA
Sunshine Lake Generic Apixaban Receives Tentative Approval in US
11 Sep 2019 //
FDA
Sunshine Lake`s Generic Tadalafil Receives Approval in US
29 Mar 2019 //
FDA
Sunshine Lake`s Generic Olmesartan Medoxomil Receives Approval in US
25 Feb 2019 //
FDA
Sunshine Lake`s Generic Apixaban Receives Tentative Approval in US
08 Feb 2019 //
FDA
Sunshine Lake`s Generic Azithromycin Receives Approval in US
11 Dec 2018 //
FDA
Sunshine Lake`s Generic Azithromycin Receives Approval in US
10 Dec 2018 //
FDA
Sunshine Lake`s Generic Azithromycin Receives Approval in US
10 Dec 2018 //
FDA
Sunshine Lake` Generic Olanzapine Receives Approval in US
22 Nov 2018 //
FDA
Sunshine Lake`s Generic Metformin Hydrochloride Receives Approval in US
19 Oct 2018 //
FDA
Sunshine Lake`s Generic Entacapone Receives Approval in US
04 Oct 2018 //
FDA
Sunshine Lake`s Generic Moxifloxacin Hydrochloride Receives Approval in US
02 Oct 2018 //
FDA
Sunshine Lake’s Generic Clarithromycin Receives Approval in the US
12 Jul 2018 //
FDA
Sunshine Lake ‘s Generic Amlodipine Besylate Receives Approval In US
05 May 2018 //
FDA
Cialis®(Tadalafil): Eli Lilly And v. Sunshine Lake Pharma
09 Apr 2018 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Sunshine Lake Pharma & HEC Pharm
05 Apr 2017 //
PATENT LITIGATION
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.